Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LEXX

Recent news which mentions LEXX

< Previous 1 2 3 4 Next >
Lexaria Bioscience Committed to Innovation and Improving Quality of Life
Tickers LEXX
Tags Partner Content Market News Small Cap
From Benzinga
Lexaria's Upcoming R&D Programs Targeting Global Markets Exceeding $160B
Tickers LEXX
Tags Market News Partner Content Global
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers ADXS ENSC FWBI GALT
Tags BZI/TFM FWBI THMO
From Benzinga
52 Biggest Movers From Yesterday
Tickers AVCT AZYO BKKT CASY
Tags AVCT Trading Ideas ISIG
From Benzinga
Lexaria Bioscience Featured in Virtual Coverage of Benzinga's Small Cap Conference
Tickers LEXX
Tags General Small Cap Market News
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
Tickers AVCT CASY CNTX CORT
Tags ROKU CTK JWEL
From Benzinga
Why Lexaria Shares Are Rising Today
Tickers LEXX
Tags Market News why it's moving Movers
From Benzinga
Read Why Lexaria Bioscience Shares Are Surging During Wednesday Premarket?
Tickers LEXX
Tags Briefs Long Ideas Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers BPTH CLXT DARE ENSC
Tags Top Gainers VYNE VALN
From Benzinga
Lexaria Bioscience Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD
Tickers LEXX
Tags General Market News Cannabis
From Benzinga
Lexaria's DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study
Tickers LEXX TM
Tags Cannabis Market News Partner Content
From Benzinga
Lexaria Bioscience's DehydraTECH(TM) Drug Delivery Tech Finding Multiple Applications
Tickers LEXX TM
Tags General Cannabis Market News
From Benzinga
Lexaria Bioscience Announces 2022 DehydraTECH(TM) R&D Programs
Tickers LEXX TM
Tags InvestorBrandNetwork Biotech Health Care
From Benzinga
Lexaria Bioscience Corp. Embarks on Ambitious Hypertension Clinical Study
Tickers LEXX
Tags Partner Content Market News General
From Benzinga
Lexaria Expands 2022 R&D Programs to Evaluate Alzheimer's, Diabetes
Tickers LEXX
Tags Market News Partner Content General
From Benzinga
Lexaria Bioscience Corp. Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology's Efficacy in Reducing/Inhibiting Seizure Activity
Tickers IPOS LEXX TECH TM
Tags IPOs General Partner Content
From Benzinga
Lexaria Bioscience Corp. to Expand Hypertension Clinical Program Through Most Ambitious Study to Date
Tickers LEXX
Tags General Partner Content Market News
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers AGRX AVRO BCRX CMPX
Tags BCRX Market News Markets
From Benzinga
Lexaria Bioscience Corp. Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex
Tickers LEXX
Tags Government Benzinga LEXX
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
Tickers JAZZ LEXX
Tags News Trading Ideas Health Care
From Benzinga
Lexaria Bioscience Corp.'s DehydraTECH(TM) Addresses the Needs of Medical THC Users
Tickers LEXX TM
Tags InvestorBrandNetwork Biotech LEXX
From Benzinga
Lexaria Starts IND-Enabling Program For DehydraTECH-CBD For Hypertension
Tickers LEXX
Tags Trading Ideas Health Care News
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers AEI ARQQ ATIF BBIG
Tags WDH SLRX CEI
From InvestorPlace
CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Results Of Human Clinical Study Showing Effective, Safe BP Reduction
Tickers CBD LEXX
Tags LEXX Health Care Benzinga
From Benzinga
Why Lexaria Bioscience Shares Are Trading Higher Today
Tickers LEXX
Tags News Benzinga LEXX
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ADAP APOP BMRN FWP
Tags TMDX ZIOP Benzinga
From Benzinga
Lexaria Bioscience's Formulated Cannabidiol Lowers Blood Pressure In Hypertension Patients
Tickers LEXX
Tags cannabinoid General hypertension
From Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets With Drug Delivery Technology
Tickers LEXX TECH
Tags pharmaceuticals Health Care Tech
From Benzinga
Lexaria's R&D Program Reveals 5 Exciting Results Within 2 Months
Tickers LEXX
Tags Biotech LEXX Benzinga
From Benzinga
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
Tickers ACB BLIN CAT CGC
Tags TLRY DOGE/USD CAT
From InvestorPlace
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.